Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 13740.42 | nM | 16562846 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 26853.44 | nM | 22620987 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 13740.42 | nM | 12027731 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 21677.04 | nM | 10.1016/j.cropro.2007.04.007 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 11246.05 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 16069.41 | nM | 18054490 | |
NPT2 | Others | Unspecified | IC50 | = | 2200 | nM | 22871217 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 22233.1 | nM | 20196571 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 11939.88 | nM | 17958396 | |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Inhibition | > | 50 | % | 20450206 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 20558.91 | nM | PubChem BioAssay data set | |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 580 | nM | 15056914 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 24717.24 | nM | 19700225 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 14554.59 | nM | 20568782 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 18407.72 | nM | DrugMatrix in vitro pharmacology data | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | IC50 | = | 14800 | nM | 25730346 |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 3500 | nM | 25651042 |
NPT2345 | Cell Line | SW626 | Homo sapiens | IC50 | = | 35400 | nM | 25651042 |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | > | 2.6 | 16499318 | ||
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 22181.96 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 14927.94 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 9311.08 | nM | 25650896 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 4446.31 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 12531.41 | nM | 20146529 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 7328.25 | nM | 21067210 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 13645.83 | nM | 10.1016/S0960-894X(01)80927-6 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 31622.78 | nM | DrugMatrix in vitro pharmacology data | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 18967.06 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 4808.39 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 22387.21 | nM | 26034885 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 20044.72 | nM | 25856683 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 19010.78 | nM | 22342628 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 15310.87 | nM | 12608850 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 11587.77 | nM | 10.6019/CHEMBL1201861 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 17298.16 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 20989.4 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 15205.48 | nM | 15646539 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 24210.29 | nM | 26010585 | |
NPT2 | Others | Unspecified | IC50 | > | 44200 | nM | 26649766 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 14588.14 | nM | 21420296 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 23659.2 | nM | 10924160 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 2432.2 | nM | 23398362 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 7194.49 | nM | 12193010 | |
NPT460 | Cell Line | MT2 | Homo sapiens | CC50 | > | 100000 | nM | 12027740 |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 15995.58 | nM | 19734910 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 14655.48 | nM | 21282058 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 18492.69 | nM | 23117170 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 13061.71 | nM | 25137549 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 15776.11 | nM | 19006372 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 17538.81 | nM | 24044895 | |
NPT91 | Cell Line | KB | Homo sapiens | Inhibition | = | 0 | % | 15270579 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 23988.33 | nM | 11754602 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 20653.8 | nM | 17432904 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 14791.08 | nM | 26296476 | |
NPT762 | Cell Line | A-431 | Homo sapiens | EC50 | > | 20 | ug/ml | 9677277 |
NPT858 | Cell Line | LNCaP | Homo sapiens | EC50 | = | 13.4 | ug/ml | 9677277 |
NPT1034 | Cell Line | Lu1 | Homo sapiens | EC50 | = | 16.1 | ug/ml | 9677277 |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | EC50 | > | 20 | ug/ml | 9677277 |
NPT91 | Cell Line | KB | Homo sapiens | EC50 | > | 20 | ug/ml | 9677277 |
NPT2 | Others | Unspecified | EC50 | = | 17.2 | ug/ml | 9677277 | |
NPT2 | Others | Unspecified | IC50 | > | 100 | ug/ml | 9677277 | |
NPT2 | Others | Unspecified | EC50 | = | 7.9 | ug/ml | 12193037 | |
NPT2049 | Cell Line | HT | Homo sapiens | EC50 | = | 8.6 | ug/ml | 8482949 |
NPT2 | Others | Unspecified | ED50 | > | 20 | ug/ml | 20695474 | |
NPT2 | Others | Unspecified | ED50 | = | 2.7 | ug/ml | 20695474 | |
NPT2 | Others | Unspecified | ED50 | = | 6.8 | ug/ml | 20695474 | |
NPT2 | Others | Unspecified | ED50 | = | 10 | ug/ml | 20695474 | |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.26 | ug/ml | 20695474 |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 12502.59 | nM | 18760509 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 16600 | nM | 18838598 |
NPT1034 | Cell Line | Lu1 | Homo sapiens | IC50 | = | 24300 | nM | 18838598 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 20400 | nM | 18838598 |
NPT1851 | Cell Line | Col2 | Homo sapiens | IC50 | = | 19200 | nM | 18838598 |
NPT858 | Cell Line | LNCaP | Homo sapiens | IC50 | = | 13100 | nM | 18838598 |
NPT2 | Others | Unspecified | IC50 | = | 32300 | nM | 18838598 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 19230.92 | nM | DrugMatrix in vitro pharmacology data | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 18879.91 | nM | DrugMatrix in vitro pharmacology data | |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | IC50 | = | 39000 | nM | 20022253 |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 1633.05 | nM | DrugMatrix in vivo data: Hematology | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 17782.79 | nM | 20192247 | |
NPT2 | Others | Unspecified | EC50 | = | 6.7 | ug/ml | DrugMatrix in vitro pharmacology data | |
NPT133 | Cell Line | ZR-75-1 | Homo sapiens | EC50 | = | 4.5 | ug/ml | DrugMatrix in vitro pharmacology data |
NPT1851 | Cell Line | Col2 | Homo sapiens | EC50 | > | 20 | ug/ml | DrugMatrix in vitro pharmacology data |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 16865.53 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 22181.96 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 18323.14 | nM | 18183025 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 16595.87 | nM | 19654408 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 23496.33 | nM | 22014827 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 2312.06 | nM | 3959033 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 2098.94 | nM | DrugMatrix in vitro pharmacology data | |
NPT91 | Cell Line | KB | Homo sapiens | Inhibition | = | 0 | % | 17908946 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 17947.34 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | ED50 | = | 12 | ug/ml | DrugMatrix in vivo data: Pathology | |
NPT453 | Cell Line | HT-1080 | Homo sapiens | ED50 | = | 2.6 | ug/ml | DrugMatrix in vivo data: Pathology |
NPT2 | Others | Unspecified | ED50 | = | 8.3 | ug/ml | DrugMatrix in vivo data: Pathology | |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.5 | ug | 19419860 |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 10592.54 | nM | 19564371 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 18663.8 | nM | 18955520 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 19230.92 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC475700 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9773 | High Similarity | NPC280877 |
0.9053 | High Similarity | NPC221421 |
0.8736 | High Similarity | NPC170862 |
0.8488 | Intermediate Similarity | NPC471475 |
0.8462 | Intermediate Similarity | NPC28227 |
0.8444 | Intermediate Similarity | NPC472505 |
0.8372 | Intermediate Similarity | NPC63020 |
0.8247 | Intermediate Similarity | NPC252295 |
0.8242 | Intermediate Similarity | NPC471042 |
0.8229 | Intermediate Similarity | NPC307164 |
0.8222 | Intermediate Similarity | NPC475509 |
0.8202 | Intermediate Similarity | NPC476458 |
0.8202 | Intermediate Similarity | NPC226988 |
0.8202 | Intermediate Similarity | NPC258153 |
0.8182 | Intermediate Similarity | NPC170038 |
0.8132 | Intermediate Similarity | NPC98270 |
0.8132 | Intermediate Similarity | NPC470223 |
0.8111 | Intermediate Similarity | NPC472740 |
0.8111 | Intermediate Similarity | NPC245866 |
0.8068 | Intermediate Similarity | NPC118987 |
0.8061 | Intermediate Similarity | NPC473155 |
0.8061 | Intermediate Similarity | NPC176845 |
0.8043 | Intermediate Similarity | NPC470051 |
0.8043 | Intermediate Similarity | NPC195640 |
0.8043 | Intermediate Similarity | NPC470050 |
0.8041 | Intermediate Similarity | NPC322063 |
0.8022 | Intermediate Similarity | NPC219011 |
0.8022 | Intermediate Similarity | NPC263974 |
0.8021 | Intermediate Similarity | NPC100257 |
0.8021 | Intermediate Similarity | NPC224410 |
0.798 | Intermediate Similarity | NPC476303 |
0.798 | Intermediate Similarity | NPC470906 |
0.7979 | Intermediate Similarity | NPC288699 |
0.7961 | Intermediate Similarity | NPC61411 |
0.7959 | Intermediate Similarity | NPC475894 |
0.7957 | Intermediate Similarity | NPC175293 |
0.7938 | Intermediate Similarity | NPC210214 |
0.7938 | Intermediate Similarity | NPC33473 |
0.7935 | Intermediate Similarity | NPC323765 |
0.7917 | Intermediate Similarity | NPC229976 |
0.7912 | Intermediate Similarity | NPC194637 |
0.79 | Intermediate Similarity | NPC474327 |
0.79 | Intermediate Similarity | NPC310981 |
0.7895 | Intermediate Similarity | NPC273199 |
0.7889 | Intermediate Similarity | NPC38642 |
0.7879 | Intermediate Similarity | NPC153792 |
0.7879 | Intermediate Similarity | NPC271387 |
0.7872 | Intermediate Similarity | NPC474845 |
0.7872 | Intermediate Similarity | NPC4309 |
0.7872 | Intermediate Similarity | NPC474719 |
0.7865 | Intermediate Similarity | NPC192744 |
0.7849 | Intermediate Similarity | NPC9231 |
0.7849 | Intermediate Similarity | NPC80590 |
0.7849 | Intermediate Similarity | NPC85698 |
0.7849 | Intermediate Similarity | NPC12774 |
0.7826 | Intermediate Similarity | NPC470011 |
0.7826 | Intermediate Similarity | NPC100391 |
0.7822 | Intermediate Similarity | NPC15396 |
0.7812 | Intermediate Similarity | NPC190442 |
0.7812 | Intermediate Similarity | NPC160506 |
0.7812 | Intermediate Similarity | NPC218301 |
0.7802 | Intermediate Similarity | NPC170985 |
0.78 | Intermediate Similarity | NPC201406 |
0.7791 | Intermediate Similarity | NPC279241 |
0.7789 | Intermediate Similarity | NPC285982 |
0.7789 | Intermediate Similarity | NPC177141 |
0.7789 | Intermediate Similarity | NPC471043 |
0.7789 | Intermediate Similarity | NPC11611 |
0.7778 | Intermediate Similarity | NPC293418 |
0.7778 | Intermediate Similarity | NPC6823 |
0.7778 | Intermediate Similarity | NPC290508 |
0.7778 | Intermediate Similarity | NPC73052 |
0.7766 | Intermediate Similarity | NPC134197 |
0.7766 | Intermediate Similarity | NPC305029 |
0.7766 | Intermediate Similarity | NPC181103 |
0.7766 | Intermediate Similarity | NPC33768 |
0.7755 | Intermediate Similarity | NPC469599 |
0.7745 | Intermediate Similarity | NPC470310 |
0.7745 | Intermediate Similarity | NPC176883 |
0.7745 | Intermediate Similarity | NPC476237 |
0.7742 | Intermediate Similarity | NPC264317 |
0.7742 | Intermediate Similarity | NPC201655 |
0.7742 | Intermediate Similarity | NPC294438 |
0.7732 | Intermediate Similarity | NPC294263 |
0.7717 | Intermediate Similarity | NPC470047 |
0.7717 | Intermediate Similarity | NPC470046 |
0.7717 | Intermediate Similarity | NPC54468 |
0.7717 | Intermediate Similarity | NPC175410 |
0.7717 | Intermediate Similarity | NPC471037 |
0.7708 | Intermediate Similarity | NPC475776 |
0.7701 | Intermediate Similarity | NPC475517 |
0.7701 | Intermediate Similarity | NPC474524 |
0.77 | Intermediate Similarity | NPC78427 |
0.77 | Intermediate Similarity | NPC16911 |
0.77 | Intermediate Similarity | NPC98868 |
0.7692 | Intermediate Similarity | NPC474484 |
0.7692 | Intermediate Similarity | NPC103754 |
0.7692 | Intermediate Similarity | NPC232625 |
0.7684 | Intermediate Similarity | NPC472739 |
0.7684 | Intermediate Similarity | NPC183374 |
0.7684 | Intermediate Similarity | NPC215831 |
0.7684 | Intermediate Similarity | NPC16377 |
0.7684 | Intermediate Similarity | NPC211162 |
0.7684 | Intermediate Similarity | NPC226863 |
0.7677 | Intermediate Similarity | NPC13949 |
0.767 | Intermediate Similarity | NPC310586 |
0.767 | Intermediate Similarity | NPC228669 |
0.767 | Intermediate Similarity | NPC189616 |
0.767 | Intermediate Similarity | NPC164835 |
0.7667 | Intermediate Similarity | NPC305835 |
0.7667 | Intermediate Similarity | NPC201459 |
0.766 | Intermediate Similarity | NPC70661 |
0.766 | Intermediate Similarity | NPC264127 |
0.766 | Intermediate Similarity | NPC2783 |
0.766 | Intermediate Similarity | NPC472738 |
0.766 | Intermediate Similarity | NPC185638 |
0.7653 | Intermediate Similarity | NPC294266 |
0.7653 | Intermediate Similarity | NPC303863 |
0.7647 | Intermediate Similarity | NPC170615 |
0.764 | Intermediate Similarity | NPC471035 |
0.764 | Intermediate Similarity | NPC212661 |
0.764 | Intermediate Similarity | NPC68828 |
0.7634 | Intermediate Similarity | NPC312660 |
0.7634 | Intermediate Similarity | NPC475745 |
0.7634 | Intermediate Similarity | NPC474482 |
0.7629 | Intermediate Similarity | NPC470230 |
0.7629 | Intermediate Similarity | NPC475416 |
0.7629 | Intermediate Similarity | NPC154101 |
0.7629 | Intermediate Similarity | NPC150383 |
0.7629 | Intermediate Similarity | NPC471901 |
0.7629 | Intermediate Similarity | NPC250753 |
0.7624 | Intermediate Similarity | NPC287676 |
0.7609 | Intermediate Similarity | NPC178676 |
0.7604 | Intermediate Similarity | NPC73995 |
0.7604 | Intermediate Similarity | NPC116620 |
0.7604 | Intermediate Similarity | NPC283409 |
0.7604 | Intermediate Similarity | NPC116146 |
0.7604 | Intermediate Similarity | NPC24772 |
0.76 | Intermediate Similarity | NPC257726 |
0.76 | Intermediate Similarity | NPC151488 |
0.76 | Intermediate Similarity | NPC187159 |
0.76 | Intermediate Similarity | NPC292133 |
0.76 | Intermediate Similarity | NPC204054 |
0.7582 | Intermediate Similarity | NPC304194 |
0.7579 | Intermediate Similarity | NPC167877 |
0.7579 | Intermediate Similarity | NPC269360 |
0.7579 | Intermediate Similarity | NPC264005 |
0.7579 | Intermediate Similarity | NPC24728 |
0.7579 | Intermediate Similarity | NPC470012 |
0.7576 | Intermediate Similarity | NPC98639 |
0.7576 | Intermediate Similarity | NPC281134 |
0.7573 | Intermediate Similarity | NPC254202 |
0.7573 | Intermediate Similarity | NPC36688 |
0.7573 | Intermediate Similarity | NPC36321 |
0.7573 | Intermediate Similarity | NPC112009 |
0.7573 | Intermediate Similarity | NPC180204 |
0.757 | Intermediate Similarity | NPC470311 |
0.7553 | Intermediate Similarity | NPC474971 |
0.7553 | Intermediate Similarity | NPC292553 |
0.7553 | Intermediate Similarity | NPC110405 |
0.7553 | Intermediate Similarity | NPC137493 |
0.7553 | Intermediate Similarity | NPC102292 |
0.7551 | Intermediate Similarity | NPC224060 |
0.7551 | Intermediate Similarity | NPC474185 |
0.7551 | Intermediate Similarity | NPC244356 |
0.7551 | Intermediate Similarity | NPC470224 |
0.7551 | Intermediate Similarity | NPC471902 |
0.7551 | Intermediate Similarity | NPC473690 |
0.7551 | Intermediate Similarity | NPC287118 |
0.7551 | Intermediate Similarity | NPC169343 |
0.7551 | Intermediate Similarity | NPC475657 |
0.7549 | Intermediate Similarity | NPC289148 |
0.7549 | Intermediate Similarity | NPC163963 |
0.7549 | Intermediate Similarity | NPC52899 |
0.7549 | Intermediate Similarity | NPC99411 |
0.7528 | Intermediate Similarity | NPC92489 |
0.7527 | Intermediate Similarity | NPC22611 |
0.7527 | Intermediate Similarity | NPC245665 |
0.7527 | Intermediate Similarity | NPC472743 |
0.7527 | Intermediate Similarity | NPC472498 |
0.7527 | Intermediate Similarity | NPC475726 |
0.7526 | Intermediate Similarity | NPC469595 |
0.7526 | Intermediate Similarity | NPC76286 |
0.7526 | Intermediate Similarity | NPC198818 |
0.7526 | Intermediate Similarity | NPC152467 |
0.7526 | Intermediate Similarity | NPC159748 |
0.7526 | Intermediate Similarity | NPC101651 |
0.7526 | Intermediate Similarity | NPC8062 |
0.7526 | Intermediate Similarity | NPC212679 |
0.7526 | Intermediate Similarity | NPC220454 |
0.7525 | Intermediate Similarity | NPC469986 |
0.7524 | Intermediate Similarity | NPC470952 |
0.7524 | Intermediate Similarity | NPC91034 |
0.75 | Intermediate Similarity | NPC475951 |
0.75 | Intermediate Similarity | NPC143979 |
0.75 | Intermediate Similarity | NPC29410 |
0.75 | Intermediate Similarity | NPC58052 |
0.75 | Intermediate Similarity | NPC97884 |
0.75 | Intermediate Similarity | NPC200054 |
0.75 | Intermediate Similarity | NPC100267 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC475700 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8261 | Intermediate Similarity | NPD7513 | Clinical (unspecified phase) |
0.8065 | Intermediate Similarity | NPD6903 | Approved |
0.8043 | Intermediate Similarity | NPD5330 | Approved |
0.8043 | Intermediate Similarity | NPD7334 | Approved |
0.8043 | Intermediate Similarity | NPD6684 | Approved |
0.8043 | Intermediate Similarity | NPD7146 | Approved |
0.8043 | Intermediate Similarity | NPD7521 | Approved |
0.8043 | Intermediate Similarity | NPD6409 | Approved |
0.7812 | Intermediate Similarity | NPD8034 | Phase 2 |
0.7812 | Intermediate Similarity | NPD8035 | Phase 2 |
0.7755 | Intermediate Similarity | NPD6356 | Clinical (unspecified phase) |
0.7742 | Intermediate Similarity | NPD7520 | Clinical (unspecified phase) |
0.7717 | Intermediate Similarity | NPD4788 | Approved |
0.7674 | Intermediate Similarity | NPD5777 | Approved |
0.7629 | Intermediate Similarity | NPD5693 | Phase 1 |
0.7551 | Intermediate Similarity | NPD6399 | Phase 3 |
0.7526 | Intermediate Similarity | NPD5207 | Approved |
0.75 | Intermediate Similarity | NPD5737 | Approved |
0.75 | Intermediate Similarity | NPD6672 | Approved |
0.7475 | Intermediate Similarity | NPD6001 | Approved |
0.7474 | Intermediate Similarity | NPD6098 | Approved |
0.7429 | Intermediate Similarity | NPD6008 | Approved |
0.7423 | Intermediate Similarity | NPD6080 | Approved |
0.7423 | Intermediate Similarity | NPD6904 | Approved |
0.7423 | Intermediate Similarity | NPD6673 | Approved |
0.732 | Intermediate Similarity | NPD5208 | Approved |
0.73 | Intermediate Similarity | NPD7900 | Approved |
0.73 | Intermediate Similarity | NPD7901 | Clinical (unspecified phase) |
0.7255 | Intermediate Similarity | NPD6084 | Phase 2 |
0.7255 | Intermediate Similarity | NPD6083 | Phase 2 |
0.7245 | Intermediate Similarity | NPD6051 | Approved |
0.7234 | Intermediate Similarity | NPD4752 | Clinical (unspecified phase) |
0.7188 | Intermediate Similarity | NPD1694 | Approved |
0.7184 | Intermediate Similarity | NPD5696 | Approved |
0.7184 | Intermediate Similarity | NPD7638 | Approved |
0.7129 | Intermediate Similarity | NPD7748 | Approved |
0.7115 | Intermediate Similarity | NPD7639 | Approved |
0.7115 | Intermediate Similarity | NPD7640 | Approved |
0.71 | Intermediate Similarity | NPD6050 | Approved |
0.7087 | Intermediate Similarity | NPD7902 | Approved |
0.7083 | Intermediate Similarity | NPD3665 | Phase 1 |
0.7083 | Intermediate Similarity | NPD3666 | Approved |
0.7083 | Intermediate Similarity | NPD4786 | Approved |
0.7083 | Intermediate Similarity | NPD3133 | Approved |
0.708 | Intermediate Similarity | NPD7115 | Discovery |
0.7075 | Intermediate Similarity | NPD6052 | Approved |
0.7059 | Intermediate Similarity | NPD5695 | Phase 3 |
0.7 | Intermediate Similarity | NPD5692 | Phase 3 |
0.6972 | Remote Similarity | NPD6899 | Approved |
0.6972 | Remote Similarity | NPD7320 | Approved |
0.6972 | Remote Similarity | NPD6881 | Approved |
0.6944 | Remote Similarity | NPD5739 | Approved |
0.6944 | Remote Similarity | NPD6675 | Approved |
0.6944 | Remote Similarity | NPD7128 | Approved |
0.6944 | Remote Similarity | NPD6402 | Approved |
0.6937 | Remote Similarity | NPD6650 | Approved |
0.6937 | Remote Similarity | NPD6649 | Approved |
0.6931 | Remote Similarity | NPD5694 | Approved |
0.6931 | Remote Similarity | NPD7515 | Phase 2 |
0.6909 | Remote Similarity | NPD6373 | Approved |
0.6909 | Remote Similarity | NPD6372 | Approved |
0.6881 | Remote Similarity | NPD5697 | Approved |
0.6875 | Remote Similarity | NPD3667 | Approved |
0.6875 | Remote Similarity | NPD4221 | Approved |
0.6875 | Remote Similarity | NPD4223 | Phase 3 |
0.6848 | Remote Similarity | NPD3702 | Approved |
0.6847 | Remote Similarity | NPD7290 | Approved |
0.6847 | Remote Similarity | NPD7102 | Approved |
0.6847 | Remote Similarity | NPD6883 | Approved |
0.6837 | Remote Similarity | NPD5329 | Approved |
0.6832 | Remote Similarity | NPD5785 | Approved |
0.6818 | Remote Similarity | NPD6011 | Approved |
0.6786 | Remote Similarity | NPD8130 | Phase 1 |
0.6786 | Remote Similarity | NPD6847 | Approved |
0.6786 | Remote Similarity | NPD6617 | Approved |
0.6786 | Remote Similarity | NPD6869 | Approved |
0.6778 | Remote Similarity | NPD4245 | Approved |
0.6778 | Remote Similarity | NPD4244 | Approved |
0.6768 | Remote Similarity | NPD3618 | Phase 1 |
0.6765 | Remote Similarity | NPD5284 | Approved |
0.6765 | Remote Similarity | NPD5281 | Approved |
0.6765 | Remote Similarity | NPD6079 | Approved |
0.6757 | Remote Similarity | NPD6014 | Approved |
0.6757 | Remote Similarity | NPD6013 | Approved |
0.6757 | Remote Similarity | NPD6012 | Approved |
0.6739 | Remote Similarity | NPD6113 | Clinical (unspecified phase) |
0.6735 | Remote Similarity | NPD4197 | Approved |
0.6735 | Remote Similarity | NPD3668 | Phase 3 |
0.6733 | Remote Similarity | NPD1695 | Approved |
0.6733 | Remote Similarity | NPD4753 | Phase 2 |
0.6733 | Remote Similarity | NPD5328 | Approved |
0.6731 | Remote Similarity | NPD4629 | Approved |
0.6731 | Remote Similarity | NPD5210 | Approved |
0.6727 | Remote Similarity | NPD6614 | Approved |
0.6727 | Remote Similarity | NPD5701 | Approved |
0.6726 | Remote Similarity | NPD8297 | Approved |
0.6726 | Remote Similarity | NPD6882 | Approved |
0.67 | Remote Similarity | NPD3573 | Approved |
0.6699 | Remote Similarity | NPD4202 | Approved |
0.6667 | Remote Similarity | NPD7632 | Discontinued |
0.6667 | Remote Similarity | NPD7094 | Approved |
0.6667 | Remote Similarity | NPD3698 | Phase 2 |
0.6667 | Remote Similarity | NPD6858 | Approved |
0.6667 | Remote Similarity | NPD8133 | Approved |
0.6637 | Remote Similarity | NPD6401 | Clinical (unspecified phase) |
0.6612 | Remote Similarity | NPD7507 | Approved |
0.66 | Remote Similarity | NPD4688 | Approved |
0.66 | Remote Similarity | NPD4138 | Approved |
0.66 | Remote Similarity | NPD5205 | Approved |
0.66 | Remote Similarity | NPD4689 | Approved |
0.66 | Remote Similarity | NPD5690 | Phase 2 |
0.66 | Remote Similarity | NPD4690 | Approved |
0.66 | Remote Similarity | NPD4693 | Phase 3 |
0.6596 | Remote Similarity | NPD6117 | Approved |
0.6583 | Remote Similarity | NPD7457 | Clinical (unspecified phase) |
0.6579 | Remote Similarity | NPD6053 | Discontinued |
0.6577 | Remote Similarity | NPD6412 | Phase 2 |
0.6571 | Remote Similarity | NPD5654 | Approved |
0.6555 | Remote Similarity | NPD6291 | Clinical (unspecified phase) |
0.6542 | Remote Similarity | NPD4225 | Approved |
0.6526 | Remote Similarity | NPD6116 | Phase 1 |
0.6522 | Remote Similarity | NPD4809 | Clinical (unspecified phase) |
0.6522 | Remote Similarity | NPD4808 | Clinical (unspecified phase) |
0.6522 | Remote Similarity | NPD6081 | Approved |
0.6517 | Remote Similarity | NPD4224 | Phase 2 |
0.6514 | Remote Similarity | NPD5211 | Phase 2 |
0.6504 | Remote Similarity | NPD7736 | Approved |
0.6481 | Remote Similarity | NPD4696 | Approved |
0.6481 | Remote Similarity | NPD5285 | Approved |
0.6481 | Remote Similarity | NPD5286 | Approved |
0.6465 | Remote Similarity | NPD5362 | Discontinued |
0.6458 | Remote Similarity | NPD6114 | Approved |
0.6458 | Remote Similarity | NPD6697 | Approved |
0.6458 | Remote Similarity | NPD6115 | Approved |
0.6458 | Remote Similarity | NPD6118 | Approved |
0.6452 | Remote Similarity | NPD7319 | Approved |
0.6449 | Remote Similarity | NPD4755 | Approved |
0.6449 | Remote Similarity | NPD5959 | Approved |
0.6441 | Remote Similarity | NPD6335 | Approved |
0.6436 | Remote Similarity | NPD3574 | Clinical (unspecified phase) |
0.6436 | Remote Similarity | NPD5280 | Approved |
0.6436 | Remote Similarity | NPD5279 | Phase 3 |
0.6436 | Remote Similarity | NPD4694 | Approved |
0.6422 | Remote Similarity | NPD5223 | Approved |
0.6415 | Remote Similarity | NPD1698 | Clinical (unspecified phase) |
0.6413 | Remote Similarity | NPD4691 | Approved |
0.6413 | Remote Similarity | NPD4747 | Approved |
0.6413 | Remote Similarity | NPD4789 | Approved |
0.641 | Remote Similarity | NPD6274 | Approved |
0.6408 | Remote Similarity | NPD7285 | Clinical (unspecified phase) |
0.6396 | Remote Similarity | NPD5141 | Approved |
0.6393 | Remote Similarity | NPD7492 | Approved |
0.6392 | Remote Similarity | NPD4195 | Approved |
0.6387 | Remote Similarity | NPD7100 | Approved |
0.6387 | Remote Similarity | NPD7101 | Approved |
0.6379 | Remote Similarity | NPD4632 | Approved |
0.6372 | Remote Similarity | NPD6686 | Approved |
0.6364 | Remote Similarity | NPD4633 | Approved |
0.6364 | Remote Similarity | NPD5225 | Approved |
0.6364 | Remote Similarity | NPD5224 | Approved |
0.6364 | Remote Similarity | NPD5226 | Approved |
0.6356 | Remote Similarity | NPD6317 | Approved |
0.6355 | Remote Similarity | NPD5221 | Approved |
0.6355 | Remote Similarity | NPD4697 | Phase 3 |
0.6355 | Remote Similarity | NPD5220 | Clinical (unspecified phase) |
0.6355 | Remote Similarity | NPD7732 | Phase 3 |
0.6355 | Remote Similarity | NPD5222 | Approved |
0.6341 | Remote Similarity | NPD6616 | Approved |
0.6337 | Remote Similarity | NPD6082 | Clinical (unspecified phase) |
0.6337 | Remote Similarity | NPD5363 | Approved |
0.6333 | Remote Similarity | NPD6054 | Approved |
0.633 | Remote Similarity | NPD4700 | Approved |
0.6306 | Remote Similarity | NPD5174 | Approved |
0.6306 | Remote Similarity | NPD5175 | Approved |
0.6304 | Remote Similarity | NPD4137 | Phase 3 |
0.6304 | Remote Similarity | NPD3700 | Clinical (unspecified phase) |
0.6304 | Remote Similarity | NPD3699 | Clinical (unspecified phase) |
0.6303 | Remote Similarity | NPD6313 | Approved |
0.6303 | Remote Similarity | NPD7328 | Approved |
0.6303 | Remote Similarity | NPD7327 | Approved |
0.6303 | Remote Similarity | NPD6314 | Approved |
0.6296 | Remote Similarity | NPD5173 | Approved |
0.629 | Remote Similarity | NPD7078 | Approved |
0.6289 | Remote Similarity | NPD3617 | Approved |
0.6281 | Remote Similarity | NPD8033 | Approved |
0.6271 | Remote Similarity | NPD6868 | Approved |
0.6263 | Remote Similarity | NPD5369 | Approved |
0.6263 | Remote Similarity | NPD4692 | Approved |
0.6263 | Remote Similarity | NPD4139 | Approved |
0.625 | Remote Similarity | NPD7516 | Approved |
0.625 | Remote Similarity | NPD3701 | Clinical (unspecified phase) |
0.623 | Remote Similarity | NPD6370 | Approved |
0.6222 | Remote Similarity | NPD3171 | Clinical (unspecified phase) |
0.6218 | Remote Similarity | NPD6009 | Approved |
0.6211 | Remote Similarity | NPD4058 | Approved |
0.6211 | Remote Similarity | NPD5733 | Approved |
0.6204 | Remote Similarity | NPD5349 | Clinical (unspecified phase) |
0.62 | Remote Similarity | NPD4269 | Approved |
0.62 | Remote Similarity | NPD4270 | Approved |
0.6198 | Remote Similarity | NPD8294 | Approved |
PubChem CID   | 386922 |
ChEMBL   | CHEMBL512065 |
ZINC   |
Molecular Weight:   | 452.33 |
ALogP:   | 2.7619 |
MLogP:   | 4.43 |
XLogP:   | 8.785 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 43.37 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 0 |
# Rings:   | 6 |
# Heavy Atoms:   | 33 |